Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54658
Gene Symbol: UGT1A1
UGT1A1
0.010 Biomarker group BEFREE UGT1A1 genotyping should be considered as a screening tool for predicting children most likely to develop gallbladder disease at a young age. 18756540 2008
Entrez Id: 1586
Gene Symbol: CYP17A1
CYP17A1
0.010 GeneticVariation group BEFREE In view of reports linking the CYP17 MspA1 polymorphism to high circulating levels of estrogens and a predisposition to other hormonally related cancers, we examined the relationship between CYP17 MspA1 variants and risk of biliary disease in a population-based case-control study in Shanghai. 16381022 2006
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.010 AlteredExpression group BEFREE In all 78 consecutive patients of gall bladder diseases were studied for p53 and c-erbB-2 expression immunohistochemically and their expression was correlated with the age, grades and stages of the disease and presence of stone. 16686942 2006
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 AlteredExpression group BEFREE In all 78 consecutive patients of gall bladder diseases were studied for p53 and c-erbB-2 expression immunohistochemically and their expression was correlated with the age, grades and stages of the disease and presence of stone. 16686942 2006
Entrez Id: 7033
Gene Symbol: TFF3
TFF3
0.010 AlteredExpression group BEFREE The aims of this study were to determine the presence of trefoil factor family-3 (TFF3) expression in biliary epithelial cells (BECs) of chronic graft-versus-host disease (cGVHD) of the liver after allogeneic hematopoietic cell transplantation, to compare such expression in chronic liver diseases (CLD) with/without predominantly biliary disease, and to assess the effect of bile duct injury on the degree of TFF3 expression in BECs of cGVHD. 16278592 2005
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.010 PosttranslationalModification group BEFREE This study demonstrates: (a) a high frequency and specificity of INK4a/ARF methylation in malignant biliary disease compared with mere cholangitis; and (b) the capability to detect these alterations reliably in endoscopically obtained bile. 12738733 2003
Entrez Id: 9166
Gene Symbol: EBAG9
EBAG9
0.010 AlteredExpression group BEFREE Here we examined RCAS1 expression in biliary diseases. 12044529 2002
Entrez Id: 907
Gene Symbol: CCT
CCT
0.010 GeneticVariation group BEFREE This study analyzed intrahepatic bile, bile duct tissue, and gallstones from 43 patients with hepatobiliary disease (PTCS group), gallbladder bile and tissue from 23 patients with gallbladder disease (CCT group), and eight patients without hepatobiliary disease (control group). 10961722 2000
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.010 GeneticVariation group BEFREE During a multicenter prospective study on mutations in the K-ras gene in pancreatic and biliary diseases, hospital diagnoses from 602 patients were reviewed by a panel of experts. 10086813 1998
Entrez Id: 1071
Gene Symbol: CETP
CETP
0.010 Biomarker group BEFREE Restriction fragment length polymorphisms (RFLPs) of apolipoprotein B (XbaI, EcoRI), apolipoprotein A-I (PstI, MspI), and cholesteryl ester transfer protein (CETP) (EcoNI, TaqIA, TaqIB) genes were examined in a series of 210 cholecystectomy patients operated on for symptomatic gallbladder disease and in 92 healthy controls. 7616125 1995
Entrez Id: 9340
Gene Symbol: GLP2R
GLP2R
0.020 Biomarker group BEFREE GLP-2 receptor activation in rodents acutely increases the volume of the gallbladder, which might explain the risk of gallbladder diseases associated with GLP-2RA treatment observed in humans. 30137354 2019
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.020 GeneticVariation group BEFREE Comparison of in silico prediction and experimental assessment of ABCB4 variants identified in patients with biliary diseases. 28587926 2017
Entrez Id: 9340
Gene Symbol: GLP2R
GLP2R
0.020 Biomarker group BEFREE Unexpectedly, reports of gallbladder disease have been associated with the use of both GLP-1R and GLP-2R agonists and after bariatric surgery, although the mechanisms remain unknown. 28580281 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.020 Biomarker group BEFREE Leptin and its receptor play several physiological roles in the canine gallbladder, and the dysregulation of leptin might play a role in the pathogenesis of gallbladder diseases such as gallbladder mucocele. 29088261 2017
Entrez Id: 5244
Gene Symbol: ABCB4
ABCB4
0.020 GeneticVariation group BEFREE The ABCB4 transporter mediates phosphatidylcholine (PC) secretion at the canalicular membrane of hepatocytes and its genetic defects cause biliary diseases. 24723470 2014
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.020 Biomarker group BEFREE Histologically, NOD.ABD biliary disease is indistinguishable from that in NOD.c3c4 mice. 21169553 2011
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation group BEFREE These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites. 16882462 2006
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.020 Biomarker group BEFREE NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. 16636131 2006
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.020 Biomarker group LHGDN Ratio of Apo B/Apo A-I > or = 1 was inversely associated with risk of gallbladder disease (OR = 0.54, 95% CI = 0.37-0.80). 14567398 2004
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation group BEFREE Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. 10613722 2000
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.020 Biomarker group BEFREE According to this model, heritability for GBD was high (h2 = 0.44+/-0.18), after accounting for the significant effects of age, leptin in both sexes, total cholesterol, and HDL cholesterol in males only. 10030401 1999
Entrez Id: 335
Gene Symbol: APOA1
APOA1
0.020 Biomarker group BEFREE Restriction fragment length polymorphisms (RFLPs) of apolipoprotein B (XbaI, EcoRI), apolipoprotein A-I (PstI, MspI), and cholesteryl ester transfer protein (CETP) (EcoNI, TaqIA, TaqIB) genes were examined in a series of 210 cholecystectomy patients operated on for symptomatic gallbladder disease and in 92 healthy controls. 7616125 1995
Entrez Id: 885
Gene Symbol: CCK
CCK
0.030 Biomarker group BEFREE To determine if use of the oral cholecystagogue, Ensure Plus (EP), in hepatobiliary scintigraphy (HBS) leads to a similar distribution of normal and abnormal gallbladder ejection fractions (GBEFs) versus other historical secondary findings of chronic biliary disease in a similar patient population compared with the conventional cholecystokinin analog, sincalide. 31789906 2020
Entrez Id: 885
Gene Symbol: CCK
CCK
0.030 Biomarker group BEFREE Despite the increasing use of fatty meal (FM) as a substitute for cholecystokinin (CCK) in pain reproduction during hepato-imino-diacetic acid (HIDA) scan in functional gallbladder disorder, there are no studies comparing the differences between CCK and FM. 28381385 2017
Entrez Id: 338
Gene Symbol: APOB
APOB
0.030 GeneticVariation group BEFREE Apolipoprotein B (APOB) gene polymorphism in patients with gallbladder disease. 17350490 2007